Matthew Venezia
Stock Analyst at Alliance Global Partners
(0.61)
# 4,232
Out of 4,704 analysts
12
Total ratings
25%
Success rate
-10.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Venezia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAPR Capricor Therapeutics | Maintained: Hold | n/a | $9.40 | - | 8 | Jul 30, 2026 | |
| NTHI NeOnc Technologies Holdings | Initiated Coverage: Buy | $13 | $5.03 | +158.45% | 1 | May 19, 2026 | |
| PLUR Pluri | Initiated Coverage: Buy | $12 | $1.36 | n/a | 1 | Jun 2, 2025 | |
| CBUS Cibus | Reiterated: Buy | $24 | $1.59 | n/a | 2 | May 9, 2025 |
Capricor Therapeutics
Jul 30, 2026
Maintained: Hold
Price Target: n/a
Current: $9.40
Upside: -
NeOnc Technologies Holdings
May 19, 2026
Initiated Coverage: Buy
Price Target: $13
Current: $5.03
Upside: +158.45%
Pluri
Jun 2, 2025
Initiated Coverage: Buy
Price Target: $12
Current: $1.36
Upside: n/a
Cibus
May 9, 2025
Reiterated: Buy
Price Target: $24
Current: $1.59
Upside: n/a